Investor Presentaiton
Pro Forma Capitalization
Overview
New debt used to finance cash consideration of
the purchase price, backstop and/or refinance
existing Term A and pay transaction fees:
+ Existing bond to remain in place, due 2028
+ $1.35bn committed financing package
Pro forma capital structure strategy:
+ No near term maturities
+ Deleverage through growth and cash flow
+ Committed to conservative leverage profile
+ Flexible capital structure to facilitate continued M&A
growth
Pro Forma Capitalization ($mm)
Cash(1)
$97
Total Debt
$1,865
9/30/20 Net Debt / LTM PF Adj. EBITDA(2)
3.6x
++ adapthealth
(1)
9/30/20 cash balance adjusted for Q4'20 closed acquisitions and expected transaction costs.
(2)
9/30/20 PF Adj. EBITDA includes full year contribution of closed acquisitions plus $50 million of run-rate synergies.
15View entire presentation